ENTEROTOXIGENIC ESCHERICHIA COLI INFECTION

Clinical trials for ENTEROTOXIGENIC ESCHERICHIA COLI INFECTION explained in plain language.

Never miss a new study

Get alerted when new ENTEROTOXIGENIC ESCHERICHIA COLI INFECTION trials appear

Sign up with your email to follow new studies for ENTEROTOXIGENIC ESCHERICHIA COLI INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

Scientists test live oral vaccine to fight two major causes of Traveler's diarrhea

⭐️ VACCINE ⭐️ Completed

This early-stage study tested a new oral vaccine designed to protect against two common bacterial causes of traveler's diarrhea: Shigella and certain E. coli strains. Researchers gave 53 healthy adults either the vaccine or a placebo to check for safety and see if it triggered an…

Matched conditions: ENTEROTOXIGENIC ESCHERICHIA COLI INFECTION

Phase: PHASE1 • Sponsor: University of Maryland, Baltimore • Aim: ⭐️ VACCINE ⭐️

Last updated Apr 03, 2026 14:43 UTC

ENTEROTOXIGENIC ESCHERICHIA COLI INFECTION

Get alerted when new ENTEROTOXIGENIC ESCHERICHIA COLI INFECTION trials appear

Scientists test live oral vaccine to fight two major causes of Traveler's diarrhea